Korean J Neuromuscul Disord Search

CLOSE


Korean Journal of Neuromuscular Disorders 2016;8(1):39-42.
Tacrolimus for Myasthenia Gravis
Yool-hee Kim, Ha Young Shin
Department of Neurology, Yonsei University College of Medicine, Seoul, Korea
중증근무력증과 타크롤리무스
김율희, 신하영
연세대학교 의과대학 신경과학교실
Abstract
Myasthenia gravis is an autoimmune disorder affecting neuromuscular junction. Corticosteroid and other immunosuppressive agents are used for the treatment of myasthenia gravis. Tacrolimus may also have a potential role in long-term supression of the immune system. There are limited but promising data to suggest beneficial effects of tacrolimus to control myasthenia gravis and to reduce corticosteroid burden. To date, the largest randomised controlled trial could not demonstrate significant differences in their primary endpoint. Therefore, additional well designed and high quality studies are necessary to determine the effects of tacrolimus on myasthenia gravis.


ABOUT
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
Department of Neurology, Ilsan Paik Hospital, Inje University College of Medicine
170, Juhwa-ro, Ilsanseo-gu, Goyang-si, Gyeonggi-do, 10380 Korea
Tel: +82-31-910-7929    Fax: +82-31-910-7368    E-mail: joongyangcho@gmail.com                

Copyright © 2024 by Korean Society of Neuromuscular Disorders.

Developed in M2PI

Close layer
prev next